Excellon Provides Operational and Financial Updates; Mill Pre-Commissioning Campaign Targeted for June Lead Investing
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting Lead Investing
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets Lead Investing
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets Lead Investing
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates Lead Investing
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update Lead Investing
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Lead Investing
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Lead Investing
